BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:With robust\, reliable and regulatory-ready analytics lying at
  the heart of clinically successful cell therapies\, now is the time to e
 levate your current workflows and strategies to prepare for clinical and 
 commercial readiness.\n\nRemaining the industry’s leading forum for cell 
 therapy analytical\, quality control\, assay\, and CMC professionals\, th
 e 7th Cell Therapy Analytical Development Summit will delve into cutting-
 edge technologies and proven strategies to aid you in demonstrating produ
 ct safety\, functionality\, and quality before heading to market.\n\nFocu
 s your learning and address your specific needs with our refined two-trac
 k format\, covering early- to late-stage assay development. No matter whe
 re you are in the product development cycle\, gain hands-on expertise fro
 m designing predictive potency assays\, through to validating and transfe
 rring methods for late-phase trials.\n\nFeaturing first-hand case studies
  and experiences from Takeda\, Arsenal Bio\, Bayer\, Genentech\, Adicet B
 io\, Quell Therapeutics\, and the National Institute of Health\, seize th
 e opportunity to benchmark against peers\, exchange solutions to persiste
 nt challenges\, and strengthen your analytical toolkit\, to excel in an i
 ncreasingly competitive cell therapy landscape.\n\nURLs:Tickets: https://
 go.evvnt.com/3185582-2?pid=185Brochure: https://go.evvnt.com/3185582-3?pi
 d=185\n\nDate and Time: On Mon\, 01 Dec 2025 08:00 - Wed\, 03 Dec 2025 17
 :00\n\nVenue Details: Revere Hotel Boston Common\, 200 Stuart Street\, Bo
 ston\, Massachusetts\, 02116\, United States\n\nCategory: Conferences | S
 cience\, Health and Medicine | Pharmaceuticals\n\nPrices:Solution Provide
 r Pricing | Conference + Workshop Day: USD 5097.00\,Solution Provider Pri
 cing | Conference Only: USD 3699.00\,Drug Developer Pricing | Conference 
 + Workshop Day: USD 4197.00\,Drug Developer Pricing | Conference Only: US
 D 2999.00\,Academic Pricing | Conference + Workshop Day: USD 3597.00\,Aca
 demic Pricing | Conference Only: USD 2599.00\n\nSpeakers: Benjamin Espen 
 | Principal Quality Engineer | Avobis Bio\, Hadar Adams | Director\, Anal
 ytical Development and Quality Control | Independent Expert\, José Peña |
  Principal Scientist | Arsenal Bio\, Laura Pierce | Biomedical Engineer |
  National Institute of Standards and Technology (NIST)\, Stephan Krause |
  Executive Director - Analytical Science and Technology\, Cell Therapy Qu
 ality | Bristol Myers Squibb\, Suning Wang | Senior Scientist | Vertex Ph
 armaceuticals\, Ajen Prasad | AD\, QC | BioNTech\, Anna Lau | Chief\, Ste
 rility Testing Service | National Institute of Health Science\, Betsy Rez
 ner | Executive Director - Quality Control and Analytical Development | F
 ate Therapeutics\, Christian Aguilera-Sandoval | Founder | SuperNova Flow
 Cytometry\, Divya Lenkala | Group Leader -DPCAD and T Cell Immunology | F
 ormerly BioNTech\, Fabian Zanella | Head of Analytical Development and Te
 sting | Genentech\, Haiyan Liu Senior | Director - Quality Control | Obsi
 dian Therapeutics\, Hiroshi Sugimoto | Director | Takeda Pharmaceutical\,
  Kathryn Simon | Vice President Global Quality | Cellectis Stem Cells\, L
 ynne Ensor | President | Independent Expert\, Michael Zeng | Senior Manag
 er | Vertex Pharmaceuticals\, Nadia Ward Business | Development Manager |
  bioMérieux\, Rebecca Malott | Quality Control Lead | University of Calga
 ry\, Rebecca Moore | Associate Director\, Analytical Development | Quell 
 Therapeutics\, Shetty Ravi | Dyavar Principal Scientist | Adicet Bio Inc.
 \, Vilma Jimenez | Director\, Quality Control and Consultant | BlueRock T
 herapeutics\, Xiaofeng Li | Principal Scientist - Chemistry\, Manufacturi
 ng\, and Controls and Analytical Development group | Aurion Biotech\, Yu 
 Qian | Director and Head of Analytical Project Leads and Cell Therapies |
  Novartis AG\, Yuan Xia| Cell Therapy and Analytical Development Staff Sc
 ientist | Bayer\, Zankar Desai | Assistant Director - Technical and Cell 
 Therapy Testing Lab | Dana Farber Cancer Institute\n
DTEND:20251203T170000
DTSTAMP:20260512T233953Z
DTSTART:20251201T080000
LOCATION:Revere Hotel Boston Common\, 200\, Stuart Street\, Boston\, Massa
 chusetts\, 02116\,
SEQUENCE:0
SUMMARY:With robust\, reliable and regulatory-ready analytics lying at the
  heart of clinically successful cell therapies\, now is the time to eleva
 te your cu...
UID:92875678-0d37-4584-8866-46db3fffc557
END:VEVENT
END:VCALENDAR